Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3018190, 9 pages
https://doi.org/10.1155/2017/3018190
Research Article

Moderate Autophagy Inhibits Vascular Smooth Muscle Cell Senescence to Stabilize Progressed Atherosclerotic Plaque via the mTORC1/ULK1/ATG13 Signal Pathway

1Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China
2Training and Postgraduate Management Department, Medical Administrative Division, Chinese PLA General Hospital, Beijing 100853, China
3Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, China

Correspondence should be addressed to Feng Cao; moc.361@8288oacgnef and Yabin Wang; moc.361@2028byw

Received 15 November 2016; Revised 15 January 2017; Accepted 21 February 2017; Published 21 June 2017

Academic Editor: Anindita Das

Copyright © 2017 Zhenli Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Higashi, S. Sukhanov, S. Y. Shai et al., “Insulin-like growth factor-1 receptor deficiency in macrophages accelerates atherosclerosis and induces an unstable plaque phenotype in apolipoprotein E-deficient mice,” Circulation, vol. 133, no. 23, pp. 2263–2278, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Xiong, Y. Yu, J. P. Montani, Z. Yang, and X. F. Ming, “Arginase-II induces vascular smooth muscle cell senescence and apoptosis through p66Shc and p53 independently of its l-arginine ureahydrolase activity: implications for atherosclerotic plaque vulnerability,” Journal of the American Heart Association, vol. 2, no. 4, article e000096, 2013. View at Google Scholar
  3. S. E. Gardner, M. Humphry, M. R. Bennett, and M. C. Clarke, “Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 35, no. 9, pp. 1963–1974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. W. H. Chappell, L. S. Steelman, J. M. Long et al., “Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health,” Oncotarget, vol. 2, no. 3, pp. 135–164, 2011. View at Publisher · View at Google Scholar
  5. G. Tarantino and D. Capone, “Inhibition of the mTOR pathway: a possible protective role in coronary artery disease,” Annals of Medicine, vol. 45, no. 4, pp. 348–356, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. A. V. Finn, M. John, G. Nakazawa et al., “Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation,” Circulation Research, vol. 105, no. 10, pp. 1003–1012, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. G. Rajapakse, G. Yepuri, J. M. Carvas et al., “Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol,” PLoS One, vol. 6, no. 4, article e19237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. O. Grootaert, P. A. da Costa Martins, N. Bitsch et al., “Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis,” Autophagy, vol. 11, no. 11, pp. 2014–2032, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. B. H. Li, Z. Ouyang, Q. Zhang et al., “TRPV1 activation impedes foam cell formation by inducing autophagy in oxLDL-treated vascular smooth muscle cells,” Cell Death & Disease, vol. 5, article e1182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Liao, J. C. Sluimer, Y. Wang et al., “Macrophage autophagy plays a protective role in advanced atherosclerosis,” Cell Metabolism, vol. 15, no. 4, pp. 545–553, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. S. Jung, K. W. Chung, J. Won Kim et al., “Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia,” Cell Metabolism, vol. 8, no. 4, pp. 318–324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Gorenne, S. Kumar, K. Gray et al., “Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis,” Circulation, vol. 127, no. 3, pp. 386–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Han, H. Tai, X. Wang et al., “AMPK activation protects cells from oxidative stress-induced senescence via autophagic flux restoration and intracellular NAD+ elevation,” Aging Cell, vol. 15, no. 3, pp. 416–427, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. J. K. Salabei and B. G. Hill, “Implications of autophagy for vascular smooth muscle cell function and plasticity,” Free Radical Biology and Medicine, vol. 65, pp. 693–703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Ido, A. Duranton, F. Lan, K. A. Weikel, L. Breton, and N. B. Ruderman, “Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes,” PLoS One, vol. 10, no. 2, article e0115341, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. C. C. Thoreen and D. M. Sabatini, “Rapamycin inhibits mTORC1, but not completely,” Autophagy, vol. 5, no. 5, pp. 725-726, 2009. View at Google Scholar
  17. N. Mizushima, T. Yoshimori, and Y. Ohsumi, “The role of Atg proteins in autophagosome formation,” Annual Review of Cell and Developmental Biology, vol. 27, pp. 107–132, 2011. View at Publisher · View at Google Scholar · View at Scopus